Intensive care unit acquired muscle weakness (ICUAW), is a common disease which influence rehabilitation, extend mechanical ventilation and length of stay in intensive care unit, and affect quality of life at hospital discharge. To prevent ICUAW, different strategies of early mobilization are recommended. But all cannot be applied in all ICU patients. Some of them benefit from heavy therapies like circulatory assistance or renal replacement therapy for example, that limit mobilization. Cycloergometer is a tool that allows continuous passive mobilization in bedridden and even unconscious patients. Neuromuscular electrical stimulation (NMES) is an alternative that helps preserve muscle mass and limit muscle atrophy. Early bedside cycle exercise coupled with NMES is an interesting new approach where application of an electrical stimulation along specific motor nerves on each lower limb, generates muscles contractions and pedaling on cycloergometer. The aim of this study is to evaluate safety and feasibility of this coupled technique called Functional Electrical Stimulation (FES) Cycling, in ICU patients.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
20
On the patient, three pairs of electrodes will be applied on tibial hamstring, quadriceps and gluteal muscles of each lower limb. Cycloergometer will be installed in passive mode. Then, optimal stimulation intensity for each muscle will be defined. During twenty minutes, neuromuscular electrical stimulation will generate a passive pedaling on cycloergometer.
Chu Saint-Etienne
Saint-Etienne, France
Tolerance
Number of FES Cycling sessions that must be stopped because of the presence of at least 1 following criteria (these criteria are qualitative (presence or absence) and therefore do not add up): * Mean arterial pressure \<65mmHg or\> 120mmHg, * Systolic blood pressure \<90 mmHg or\> 200 mmHg, * Heart rate \<50 or\> 130 / min * Occurrence of atrial or ventricular arrhythmia * Respiratory rate \> 35 / min, * Pulse oxygen saturation \<90% * Intracranial pressure \> 20mmHg. * Mean mean arterial velocity measured by transcranial Doppler \<30 cm / s
Time frame: During the FES Cycling session (day 1)
Systolic blood pressure
Haemodynamic repercussions of a FES Cycling session measured by Systolic blood pressure
Time frame: During the FES Cycling session (day 1)
Haemodynamic tolerance Heart rate
Haemodynamic repercussions of a FES Cycling session measured by Heart rate
Time frame: During the FES Cycling session (day 1)
Cardiac output measured
Haemodynamic repercussions of a FES Cycling session measured by Cardiac output measured in transthoracic echocardiography
Time frame: During the FES Cycling session (day 1)
Fick equation
Haemodynamic repercussions of a FES Cycling session measured by oxygen consumption according to the Fick equation (cardiac output x (arterial content in O2 - venous content in O2))
Time frame: During the FES Cycling session (day 1)
Arterial lactates
Haemodynamic repercussions of a FES Cycling session measured Arterial lactates
Time frame: During the FES Cycling session (day 1)
Venous oxygen
Haemodynamic repercussions of a FES Cycling session measured by Venous oxygen saturation
Time frame: During the FES Cycling session (day 1)
Amine dosage
Haemodynamic repercussions of a FES Cycling session measured by Amine dosage
Time frame: During the FES Cycling session (day 1)
Respiratory tolerance Oxygen saturation
Respiratory repercussions of a FES Cycling session measured by Oxygen saturation
Time frame: During the FES Cycling session (day 1)
Respiratory tolerance
Respiratory repercussions of a FES Cycling session measured by Respiratory rate
Time frame: During the FES Cycling session (day 1)
Respiratory rate
Respiratory repercussions of a FES Cycling session measured by PaCO2 and PaO2
Time frame: During the FES Cycling session (day 1)
Diastolic cerebral artery
Neurological repercussions of a FES Cycling session measured by diastolic average cerebral artery measured by transcranial Doppler
Time frame: During the FES Cycling session (day 1)
Pulsatility index
Neurological repercussions of a FES Cycling session measured by Average of pulsatility index, measured by transcranial Doppler.
Time frame: During the FES Cycling session (day 1)
Intracranial pression
Neurological repercussions of a FES Cycling session measured by, If sensors present, Intracranial pression.
Time frame: During the FES Cycling session (day 1)
Cerebral perfusion pressure
Neurological repercussions of a FES Cycling session measured by, If sensors present, Cerebral perfusion pressure.
Time frame: During the FES Cycling session (day 1)
Cerebral tissue oxygen pressure
Neurological repercussions of a FES Cycling session measured by, If sensors present, Cerebral tissue oxygen pressure.
Time frame: During the FES Cycling session (day 1)
FES cycling installation
FES Cycling technical feasibility measured by installation and uninstallation times Cycloergometer,
Time frame: After the FES Cycling session (day 1)
FES Cycling technical feasibility
FES Cycling technical feasibility measured by number of persons needed.
Time frame: After the FES Cycling session (day 1)
Duration of FES Cycling session
FES Cycling technical feasibility measured by total duration of FES Cycling session.
Time frame: After the FES Cycling session (day 1)
Failure FES Cycling session
FES Cycling technical feasibility measured by number of procedural failures.
Time frame: After the FES Cycling session (day 1)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.